Coherus Oncology Inc.
CHRS | NASDAQ
$1.33
-$0.04 (-2.92%)
Sep 22, 2026, 11:25 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 88.88M | 125.99M | 102.89M | 63.55M | 417.2M | 541.16M |
Short-Term Investments | 83.25M | n/a | 14.86M | 128.13M | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 4.05M | 50.47M | 77.18M | 84.93M | 65.64M | 60.5M |
Receivables | 18.42M | 122.33M | 260.52M | 109.96M | 123.02M | 157.05M |
Inventory | 3.17M | 70.09M | 62.61M | 38.79M | 37.64M | 44.23M |
Other Current Assets | 6.23M | 11.53M | 11.1M | 22.92M | 10.8M | n/a |
Total Current Assets | 206.71M | 341.58M | 475.63M | 381.23M | 602.32M | 767.48M |
Property-Plant & Equipment | 1.35M | 2.84M | 5.12M | 8.75M | 7.81M | 10.11M |
Goodwill & Intangibles | 46.24M | 53.65M | 71.67M | 5.93M | 3.56M | 3.56M |
Total Long-Term Assets | 51.64M | 106.95M | 153.97M | 99.61M | 77.01M | 74.17M |
Total Assets | 258.34M | 448.53M | 629.6M | 480.85M | 679.33M | 841.65M |
Account Payables | 9.92M | 28.46M | 35.22M | 11.53M | 16.16M | 15.2M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 16.07M | 33.11M | 21.52M | 22.61M | 22.01M | 22.24M |
Total Current Liabilities | 141.88M | 282.98M | 331.77M | 138.69M | 165.33M | 145.65M |
Long-Term Debt | 37.05M | 264.93M | 473.37M | 471.06M | 408.28M | 404.02M |
Other Long-Term Liabilities | 15.84M | 28.23M | 11.46M | 3.47M | 750K | 1.05M |
Total Long-Term Liabilities | 55.45M | 297.54M | 491.26M | 479.57M | 416.28M | 415.02M |
Total Liabilities | 197.33M | 580.52M | 823.03M | 618.27M | 581.61M | 560.68M |
Total Debt | 40.34M | 269.9M | 480.84M | 480.42M | 419.02M | 417.1M |
Book Value | 61.01M | -131.99M | -193.43M | -137.42M | 97.73M | 280.97M |
Book Value Per Share | 0.51 | -1.15 | -2.05 | -1.77 | 1.30 | 3.37 |
Common Stock | 12K | 12K | 11K | 8K | 7K | 7K |
Retained Earnings | -1.38B | -1.55B | -1.58B | -1.34B | -1.05B | -762.75M |
Comprehensive Income | -195K | -275K | -248K | -249K | -270K | -270K |
Shareholders Equity | 61.01M | -131.99M | -193.43M | -137.42M | 97.73M | 280.97M |
Total Investments | 83.25M | n/a | 14.86M | 128.13M | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove CHRS